Furthermore, by specific siRNA silencing of the receptors aforementioned we observed that only GPR23-silencing reduced the GBP antiproliferative effects in two different glioma cell lines, mainly that induced by GUA. The gene discussed is LPAR4; the disease is central nervous system cancer.